Sign in
4

Changes in Ownership

Intellia Therapeutics, Inc. Filed Acc 0001209191-20-040251

President and CEO sold 5,000 shares at $21.83 ($109,150)

  • President and CEO acquired 5,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

LEONARD JOHN M. · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-07-01 Exercise or conversion : show line 1 in the form +5,000 $6.83 $34,150 472,352 D
2020-07-01 Sale : show line 2 in the form −5,000 $21.83 $109,150 467,352 D
Open-market sales · 5,000 sh · avg $21.83 · $109,150

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-07-01 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −5,000 340,234 D
Loading xslF345X03/doc4.xml…